Delcath Systems, Inc.
DCTH- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000872912
No open-market purchases or sales by Delcath Systems, Inc. insiders were filed in the last 90 days; 119 institutions reported holding it in 13F filings for Q2 2026, worth $219.2M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Delcath Systems, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 22 | 24 | +2 |
| Shares | 847.1K | 1.27M | +423.3K (+50.0%) |
| Value | $3.05M | $6.31M | +$3.26M (+107.0%) |
New holders (4)
Institutions that held Delcath Systems, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ikarian Capital, LLC | 360,569 | $1.08M | 0.45% |
| Advisors Capital Management, LLC | 27,021 | $155.0K | 0.00% |
| Renaissance Technologies LLC | 12,100 | $70.0K | 0.00% |
| JPMorgan Chase & Co | 1,805 | $10.0K | 0.00% |
Sold out (2)
Institutions that held Delcath Systems, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Citadel Advisors LLC | 24,188 | $87.1K |
| IFP Advisors, Inc | 1 | – |